Ortal Calfon-Peretz

Ortal Calfon-Peretz

Lev Academic Center (JCT)
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
RWRachel Weitzman
Rachel Weitzman
OCOrtal Calfon-Peretz
Ortal Calfon-Peretz
TSTrishna Saha
Trishna Saha
NBNaamah Bloch
Naamah Bloch
KZKarin Ben Zaken
Karin Ben Zaken
ASAbraham O. Samson
Abraham O. Samson
Malaria is a prevalent parasitic disease that is estimated to kill between one and two million people—mostly children—every year. Here, we query PubMed for malaria drug resistance and plot the yearly citations of 14 common antimalarials. Remarkably, most antimalarial drugs display cyclic resistance patterns, rising and falling over four decades. The antimalarial drugs that exhibit cyclic resistance are quinine, chloroquine, mefloquine, amodiaquine, artesunate, artemether, sulfadoxine, doxycycline, halofantrine, piperaquine, pyrimethamine, atovaquone, artemisinin, and dihydroartemisinin. Exceptionally, the resistance of the two latter drugs can also correlate with a linear rise. Our predicted antimalarial drug resistance is consistent with clinical data reported by the Worldwide Antimalarial Resistance Network (WWARN) and validates our methodology. Notably, the cyclical resistance suggests that most antimalarial drugs are sustainable in the end. Furthermore, cyclic resistance is clinically relevant and discourages routine monotherapy, in particular, while resistance is on the rise. Finally, cyclic resistance encourages the combination of antimalarial drugs at distinct phases of resistance.

Verified
Journal Article
Open access
PDF file
OCOrtal Calfon-Peretz
Ortal Calfon-Peretz
RWRachel Weitzman
Rachel Weitzman
MAMoshe Amitay
Moshe Amitay
ASAbraham O. Samson
Abraham O. Samson
Thank you for the opportunity to respond to comments gracefully raised by van der Pluijm et al.